Research Article: Bioequivalence of twice-daily oral tacrolimus in transplant recipients: More evidence for consensus?

Date Published: November 14, 2017

Publisher: Public Library of Science

Author(s): Simon Ball

Abstract: In this Perspective on the clinical trial by Rita Alloway and colleagues, Simon Ball explains the benefits to healthcare systems and individual patients of the bioequivalence established between generic and brand-name formulations of an immunosuppressive drug in transplant recipients.

Partial Text:



Leave a Reply

Your email address will not be published.